SECsense Logo

Eton Pharmaceuticals 8-K Report: Key Updates as of December 17, 2024

$ETON
Form 8-K
Filed on: 2024-12-17
Source
Eton Pharmaceuticals 8-K Report: Key Updates as of December 17, 2024

Based on the provided section of the financial report, here are the key extracted insights:

  1. Entity Information:
  • Company Name: Eton Pharmaceuticals, Inc.
  • CIK (Central Index Key): 0001710340
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-38738
  • EIN (Employer Identification Number): 37-1858472
  • Address: 21925 W. Field Parkway, Suite 235, Deer Park, IL 60010
  • Phone Number: 847-787-7361
  • Stock Ticker Symbol: ETON
  • Exchange: NASDAQ
  1. Filing Type:
  • Form: 8-K (Current Report)
  1. Filing Date:
  • Date of Report: December 17, 2024
  1. Reporting Period:
  • Start Date: December 17, 2024
  • End Date: December 17, 2024
  1. XML and XBRL Information:
  • The document is formatted in XBRL (eXtensible Business Reporting Language), which is used by the SEC for reporting financial data.
  1. Schema Reference:
  • The report refers to a schema file named "eton-20241217.xsd".

Insights:

  • The filing is a current report (8-K) indicating that Eton Pharmaceuticals has likely disclosed significant events or changes impacting the company on this specific date.
  • The details regarding the company's identification and contact information are crucial for stakeholders looking to follow up or verify the information.
  • The fact that this filing is associated with the SEC suggests it is important for compliance and regulatory purposes, and it may contain material information relevant to investors.
  • As this is a fresh report dated December 17, 2024, it indicates that the company is actively engaged in timely disclosure practices, which is important for transparency in the financial markets.

This information can be critical for investors, analysts, and stakeholders who are interested in the company's current operations and regulatory compliance.